Top Markets
Coin of the day
Upstream Bio, Inc. Upstream Bio, Inc.

Upstream Bio, Inc.

UPB
Rangering i aksjer #15351
Upstream Bio, Inc. is a biotechnology company in the clinical development... Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Established in 2021, Upstream Bio maintains its operational base in Waltham, Massachusetts.
Aksjekurs
$6.56
Markedsverdi
$357.23M
Endring (1 dag)
-0.84%
Endring (1 år)
-61.68%
Land
US
Handel Upstream Bio, Inc. (UPB)

Kategori

Aksjeprishistorikk for Upstream Bio, Inc. (UPB)
Høyeste sluttskurs: $6.56 den 2026-09-01

Laveste sluttskurs: $24.44 den 2024-10-01
Aksjeprishistorikk for Upstream Bio, Inc. fra 2024 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -45.19%
2025 43.52%
2024 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$548.15 40.18%
US
$1.03K 44.14%
NL
$153.87 538.73%
US
$121.37 -11.93%
AU
$748.60 4.92%
CH